These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10573703)

  • 1. [New immunosuppressive agents].
    Socié G; Thervet E
    Pathol Biol (Paris); 1999 Oct; 47(8):827-35. PubMed ID: 10573703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The benefits of new immunosuppressive treatments in adult kidney transplantation].
    Pastural M; Abtahi M; Lang P
    Presse Med; 2002 Mar; 31(9):421-6. PubMed ID: 11933740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive agents in organ transplantation: past, present, and future.
    Hong JC; Kahan BD
    Semin Nephrol; 2000 Mar; 20(2):108-25. PubMed ID: 10746855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive drugs and renal transplantation].
    Stallone G; Infante B; Gesualdo L
    G Ital Nefrol; 2005; 22 Suppl 33():S76-9. PubMed ID: 16419011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist].
    Hulin A
    Ann Pharm Fr; 2008 Mar; 66(2):102-14. PubMed ID: 18570909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
    Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
    J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapamycin: a new immunosuppressive agent capable of inhibiting chronic rejection?].
    Viklický O; Matl I
    Cas Lek Cesk; 2001 Jan; 140(1):22-5. PubMed ID: 11242980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
    Buhaescu I; Segall L; Goldsmith D; Covic A
    J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation signal inhibitors and cardiac allograft vasculopathy.
    Raichlin E; Kushwaha SS
    Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of transplant rejection: current treatment guidelines and future developments.
    Perico N; Remuzzi G
    Drugs; 1997 Oct; 54(4):533-70. PubMed ID: 9339960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
    Saudek F; Malaise J; Boucek P; Adamec M;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation, past, present and future.
    Ponticelli C; Tarantino A; Vegeto A
    J Nephrol; 1999; 12 Suppl 2():S105-10. PubMed ID: 10688409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus in clinical practice--renal transplantation.
    Pascual J
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Perspectives of immunosuppressive therapy].
    Meuer S; Sido B; Dengler T
    Chirurg; 1996 Apr; 67(4):310-7. PubMed ID: 8646915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lck inhibitors as a therapeutic approach to autoimmune disease and transplant rejection.
    Kamens JS; Ratnofsky SE; Hirst GC
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1213-9. PubMed ID: 11717807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New advances in antirejection therapy.
    Chan M; Pearson GJ
    Curr Opin Cardiol; 2007 Mar; 22(2):117-22. PubMed ID: 17284990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.